IL2 and neoplasm: By inducing T cell expression of CD25, IL-2 enhances T cell signaling, thereby increasing the anti-tumor efficacy of cytotoxic T-lymphocytes (CTL) and chimeric antigen receptor T cells (CAR-T) used in immunotherapy (74).